<mediadc-video-embed data-state="{"cms.site.owner":{"_ref":"00000161-3486-d333-a9e9-76c6fbf30000","_type":"00000161-3461-dd66-ab67-fd6b93390000"},"cms.content.publishDate":1656457727913,"cms.content.publishUser":{"_ref":"00000168-ed87-defd-a17f-fdd754cd0002","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"cms.content.updateDate":1656457727913,"cms.content.updateUser":{"_ref":"00000168-ed87-defd-a17f-fdd754cd0002","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"rawHtml":"
var _bp = _bp||[]; _bp.push({ "div": "Brid_56457716", "obj": {"id":"27789","width":"16","height":"9","video":"1041806"} }); ","_id":"00000181-ac93-da7c-a7c7-edf707fc0000","_type":"2f5a8339-a89a-3738-9cd2-3ddf0c8da574"}”>Video Embed
The Biden administration is ramping up its response to the monkeypox outbreak in the United States by shoring up supplies of vaccines and expanding access to tests at commercial labs.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
Already a member? Log in
